A Erfurth|V Arolt - JoVE Visualize

Showing results (41-50 of 174) with videos related to

Pageof 18

Sort By:

Psychopathology|August 11, 1998

Relations between neuropsychological vulnerability markers and negative symptoms in schizophreniaT Suslow, K Junghanns, C Weitzsch, et al.

Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|October 11, 2001

[A critique of the construct "alexithymia" and its measurement--the weakness of self-report and the opportunities of an objective assessment approach]T Suslow, A Kersting, P Ohrmann, et al.

Der Nervenarzt|May 1, 1995

[Psychiatric consultation service in a university clinic. An empirical study of characteristic performance]V Arolt, A Gehrmann, U John, et al.

Der Nervenarzt|December 17, 2009

[Neurogenetics of emotional processes. Neuroimaging findings as endophenotypes for depression]U Dannlowski, C Konrad, V Arolt, et al.

Brain Research. Brain Research Protocols|May 1, 1997

Sensitive measurement of agonist-stimulated [3H]inositol monophosphate accumulation in rat cortical miniprismsA Erfurth, R J Wurtman

Neuroscience Letters|June 23, 1995

Effects of unilateral lesion of the nucleus basalis magnocellularis on carbachol- and serotonin-stimulated [3H]inositolmonophosphate accumulation in rat fronto-parietal cortexA Erfurth, T C Holmes

Fortschritte Der Neurologie-Psychiatrie|June 22, 2001

[The course of infantile autism through adulthood. An overview of long-term follow-up data]K Schonauer, M Klar, H E Kehrer, et al.

Psychopathology|September 11, 2001

The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapyR Feldmann, W P Hornung, G Buchkremer, et al.

Scandinavian Journal of Psychology|December 29, 2000

20-Item Toronto Alexithymia Scale: do difficulties describing feelings assess proneness to shame instead of difficulties symbolizing emotions?T Suslow, U S Donges, A Kersting, et al.

Molecular Psychiatry|May 24, 2000

Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatmentV Arolt, M Rothermundt, K P Wandinger, et al.

Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:

Pageof 18

Psychopathology|August 11, 1998

Relations between neuropsychological vulnerability markers and negative symptoms in schizophreniaT Suslow, K Junghanns, C Weitzsch, et al.

Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|October 11, 2001

[A critique of the construct "alexithymia" and its measurement--the weakness of self-report and the opportunities of an objective assessment approach]T Suslow, A Kersting, P Ohrmann, et al.

Der Nervenarzt|May 1, 1995

[Psychiatric consultation service in a university clinic. An empirical study of characteristic performance]V Arolt, A Gehrmann, U John, et al.

Der Nervenarzt|December 17, 2009

[Neurogenetics of emotional processes. Neuroimaging findings as endophenotypes for depression]U Dannlowski, C Konrad, V Arolt, et al.

Brain Research. Brain Research Protocols|May 1, 1997

Sensitive measurement of agonist-stimulated [3H]inositol monophosphate accumulation in rat cortical miniprismsA Erfurth, R J Wurtman

Neuroscience Letters|June 23, 1995

Effects of unilateral lesion of the nucleus basalis magnocellularis on carbachol- and serotonin-stimulated [3H]inositolmonophosphate accumulation in rat fronto-parietal cortexA Erfurth, T C Holmes

Fortschritte Der Neurologie-Psychiatrie|June 22, 2001

[The course of infantile autism through adulthood. An overview of long-term follow-up data]K Schonauer, M Klar, H E Kehrer, et al.

Psychopathology|September 11, 2001

The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapyR Feldmann, W P Hornung, G Buchkremer, et al.

Scandinavian Journal of Psychology|December 29, 2000

20-Item Toronto Alexithymia Scale: do difficulties describing feelings assess proneness to shame instead of difficulties symbolizing emotions?T Suslow, U S Donges, A Kersting, et al.

Molecular Psychiatry|May 24, 2000

Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatmentV Arolt, M Rothermundt, K P Wandinger, et al.

Pageof 18